Luke Timmerman

Biotech journalist. Founder @TimmermanReport.

[Luke Timmerman @ldtimmerman]

Join the Timmerman Traverse. WATCH alumni Ted Love, Amy Abernethy, Doug Fambrough and Bonnie Anderson. https://t.co/49ZC5b4mKy

[Luke Timmerman @ldtimmerman]

Small molecules to correct disease. Listen to @srikosuri of @OctantBio on The Long Run. Sponsors: @AlphaSenseInc and Dash Bio. https://t.co/mFkC5qoxzz

[Luke Timmerman @ldtimmerman]

@JMaraganore Excellent choice. #gobadgers

[Luke Timmerman @ldtimmerman]

Beyond Language: Why Drug Discovery Needs a Different Kind of AI. Guest editorial by Woody Sherman of PsiThera. https://t.co/HsLyEcZqil

[Luke Timmerman @ldtimmerman]

Reimagining Science for the AI Era. Listen to @beckypferdehirt CEO of Radial @AsteraInstitute discuss the $500M nonprofit seeking to create better conditions for AI in biology. Sponsors: @AlphaSenseInc Dash Bio. https://t.co/UOqrjbysem

[Luke Timmerman @ldtimmerman]

Biotech in the Balance: Saving a Strategic Industry in an Age of Public Distrust. Listen to @jmaxlevin discuss his new book on The Long Run. Sponsored by: @AlphaSenseInc & Dash Bio. https://t.co/sDIHscoWP6

[Luke Timmerman @ldtimmerman]

Orexin drugs for narcolepsy and more. Listen to Richard Pops @popsalks discuss the emerging opportunity, and his 35-year-career, on The Long Run. Sponsored by @AlphaSenseInc & Dash Bio. https://t.co/Qr6oJ8AwzB

[Luke Timmerman @ldtimmerman]

Small molecule synthesis made faster for the AI era: Listen to Martin Burke on The Long Run. Sponsors: @AlphaSenseInc and Dash Bio. https://t.co/D990phgzg8

[Luke Timmerman @ldtimmerman]

PhaseV Steps Up for Young Cancer Researchers. New Major Sponsor of Timmerman Traverse for Damon Runyon Cancer Research Foundation. Next trip: Sierras, Aug. 2-5. https://t.co/lvbuUGj0A6

[Luke Timmerman @ldtimmerman]

Big Monday: RevMed, Spyre, Ideaya, Allogene & Telix Make News. https://t.co/ySBYxwgKTU

[Luke Timmerman @ldtimmerman]

A couple cool cancer drug startups profiled this week in TR. Sidewinder Therapeutics with $137M for bispecific ADCs https://t.co/tJcQwI7C4U and Stipple Bio with $100M for novel targets for antibody drugs. https://t.co/rbXkuaRpoe

[Luke Timmerman @ldtimmerman]

Computation, Chemistry & Culture for Drug Discovery: Nimbus Therapeutics CEO Abbas Kazimi is the latest guest on The Long Run. Sponsored by @AlphaSenseInc and Dash Bio. https://t.co/XCysW6El1o

[Luke Timmerman @ldtimmerman]

Inspired by Mother Nature, Discovering New Drugs. @viswacolluru of @lifeschemistry is the latest guest on The Long Run. Sponsored by @AlphaSenseInc and Dash Bio. https://t.co/F01HMam6Ul

[Luke Timmerman @ldtimmerman]

Europe's Biotech Investing Crisis: @OtelloVC Otello Stampacchia of Omega Funds discusses the drive to increase EU biotech investment on The Long Run. Sponsored by @AlphaSenseInc & Dash Bio https://t.co/ORIeN8IDEq

[Luke Timmerman @ldtimmerman]

Why 200 people have joined the Timmerman Traverse. Request an invite to the next hike in the Sierras. https://t.co/2lUmYpXei8

[Luke Timmerman @ldtimmerman]

Join the next Timmerman Traverse for Damon Runyon! https://t.co/OghT8OAcpM

[Luke Timmerman @ldtimmerman]

Physical challenge, camaraderie, and giving back. Timmerman Traverse Kilimanjaro 2026. https://t.co/PxY6KRM12Y via @YouTube

[Luke Timmerman @ldtimmerman]

T-cell engagers for autoimmunity. Listen to Ken Song describe the opportunity as CEO of San Diego-based Candid Therapeutics. Sponsored by @AlphaSenseInc & Dash Bio. https://t.co/Ct2viH00c4

[Luke Timmerman @ldtimmerman]

Discovering Drugs for Cancer and Autoimmunity. Listen to @Satpathology on The Long Run podcast. Sponsored by @AlphaSenseInc Dash Bio. https://t.co/02keVFdqzj

[Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 @BLLPHD]

Very well written! - Philadelphia Cell Therapy Experts on Summiting the Next Peak in CAR-T: From Discovery to Delivery - and a tribute to CAR T patient Brad Watts https://t.co/IRqHF4X0VF